Growth Metrics

Gilead Sciences (GILD) Net Income Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.25%
Dec 31, 2025 10.36%
Sep 30, 2025 53.94%
Jun 30, 2025 20.93%
Mar 31, 2025 -3.08%
Dec 31, 2024 20.51%
Sep 30, 2024 25.17%
Jun 30, 2024 -2.94%
Mar 31, 2024 -32.73%
Dec 31, 2023 27.04%
Sep 30, 2023 0.69%
Jun 30, 2023 -10.60%
Mar 31, 2023 -8.56%
Dec 31, 2022 19.57%
Sep 30, 2022 -8.01%
Jun 30, 2022 -18.04%
Mar 31, 2022 -66.15%
Dec 31, 2021 -34.42%
Sep 30, 2021 -4.90%
Jun 30, 2021 -15.38%
Mar 31, 2021 -13.55%
Dec 31, 2020 -19.91%
Sep 30, 2020 -40.14%
Jun 30, 2020 -22.37%
Mar 31, 2020 -18.71%
Dec 31, 2019 -27.34%
Sep 30, 2019 -19.42%
Jun 30, 2019 -12.47%
Mar 31, 2019 -2.41%
Dec 31, 2018 -11.46%
Sep 30, 2018 21.73%
Jun 30, 2018 18.83%
Mar 31, 2018 16.48%
Dec 31, 2017 -46.89%
Sep 30, 2017 32.22%
Jun 30, 2017 34.16%
Mar 31, 2017 43.89%
Dec 31, 2016 36.18%
Sep 30, 2016 35.15%
Jun 30, 2016 36.33%
Mar 31, 2016 40.68%
Dec 31, 2015 49.55%
Sep 30, 2015 45.58%
Jun 30, 2015 44.69%
Mar 31, 2015 38.43%
Dec 31, 2014 18.00%
Sep 30, 2014 32.36%
Jun 30, 2014 45.02%
Mar 31, 2014 30.53%